Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Swift

Showing results (271-280 of 307) with videos related to

Pageof 31
Sort By:
Kidney360|April 4, 2022
The Characteristics, Dynamics, and the Risk of Death in COVID-19 Positive Dialysis Patients in London, UKDalvir Kular, Irina Chis Ster, Alexander Sarnowski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2024
A comparison of sodium-glucose co-transporter 2 inhibitor kidney outcome trial participants with a real-world chronic kidney disease primary care populationAnna K Forbes, William Hinton, Michael D Feher, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 4, 2026
The RNA-binding protein Imp1 promotes a Spdef transcriptional program and mucus fucosylation during necrotizing enterocolitisKevin A Swift, Alexandria J Shumway, Molly Aloia, et al.
Experimental Hematology|August 7, 2022
Efficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing Combination RegimenJonathan Afari, Tanya M Spektor, Carley Turner, et al.
BMJ Open|June 4, 2025
Feasibility randomised controlled trial to assess the delivery of a novel isometric exercise intervention for people diagnosed with uncomplicated stage 1 hypertension in the National Health Service: key quantitative findingsJim D Wiles, Ellie Santer, Melanie Rees-Roberts, et al.
European Journal of Haematology|May 16, 2021
Baseline serum B-cell maturation antigen levels predict time to disease progression for patients with smoldering multiple myelomaSean Bujarski, Marissa-Skye Goldwater, Bernard Sean Regidor, et al.
JCI Insight|July 12, 2022
Junctional adhesion molecule-A deletion increases phagocytosis and improves survival in a murine model of sepsisNathan J Klingensmith, Katherine T Fay, David A Swift, et al.
British Journal of Haematology|September 29, 2011
A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patientsJames R Berenson, Ori Yellin, Chien-Shing Chen, et al.
Physics in Medicine and Biology|August 8, 2002
MR imaging of the lungs with hyperpolarized helium-3 gas transported by airJ M Wild, J Schmiedeskamp, M N J Paley, et al.
Clinical Kidney Journal|January 15, 2025
Iron management and exercise training in individuals with chronic kidney disease: lived experiencesCourtney J Lightfoot, Sharlene A Greenwood, Elham Asgari, et al.
Pageof 31

Showing results (271-280 of 307) with videos related to

Sort By:
Pageof 31
Kidney360|April 4, 2022
The Characteristics, Dynamics, and the Risk of Death in COVID-19 Positive Dialysis Patients in London, UKDalvir Kular, Irina Chis Ster, Alexander Sarnowski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 23, 2024
A comparison of sodium-glucose co-transporter 2 inhibitor kidney outcome trial participants with a real-world chronic kidney disease primary care populationAnna K Forbes, William Hinton, Michael D Feher, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 4, 2026
The RNA-binding protein Imp1 promotes a Spdef transcriptional program and mucus fucosylation during necrotizing enterocolitisKevin A Swift, Alexandria J Shumway, Molly Aloia, et al.
Experimental Hematology|August 7, 2022
Efficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing Combination RegimenJonathan Afari, Tanya M Spektor, Carley Turner, et al.
BMJ Open|June 4, 2025
Feasibility randomised controlled trial to assess the delivery of a novel isometric exercise intervention for people diagnosed with uncomplicated stage 1 hypertension in the National Health Service: key quantitative findingsJim D Wiles, Ellie Santer, Melanie Rees-Roberts, et al.
European Journal of Haematology|May 16, 2021
Baseline serum B-cell maturation antigen levels predict time to disease progression for patients with smoldering multiple myelomaSean Bujarski, Marissa-Skye Goldwater, Bernard Sean Regidor, et al.
JCI Insight|July 12, 2022
Junctional adhesion molecule-A deletion increases phagocytosis and improves survival in a murine model of sepsisNathan J Klingensmith, Katherine T Fay, David A Swift, et al.
British Journal of Haematology|September 29, 2011
A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patientsJames R Berenson, Ori Yellin, Chien-Shing Chen, et al.
Physics in Medicine and Biology|August 8, 2002
MR imaging of the lungs with hyperpolarized helium-3 gas transported by airJ M Wild, J Schmiedeskamp, M N J Paley, et al.
Clinical Kidney Journal|January 15, 2025
Iron management and exercise training in individuals with chronic kidney disease: lived experiencesCourtney J Lightfoot, Sharlene A Greenwood, Elham Asgari, et al.
Pageof 31